ESCHM-ISCH-ISB 2021 FUKUOKA HOME
  Basic Information on Abstract Submission  
     
 
Eligibility of Abstract Submission
The office of the 2nd Joint Meeting of ESCHM-ISCH-ISB 2021 asks to submit abstracts for both Free Communication and Symposium under the following criteria:
1 All participants must register for the 2nd Joint Meeting of ESCHM-ISCH-ISB 2021 and pay the registration fee through the website. (https://eschmischisb.confit.atlas.jp/login).
2 The abstract submission is free. However, at least one of the authors (the first author, presenting author or senior author) require the registration process and attending the Joint Meeting. We therefore recommend submitters of abstracts to register for the Joint Meeting at the time of abstract submission.
3 The abstract content must fit into one of this Joint Meeting Abstract Review Categories for both Free Communication and Symposium.
 
   
 
Basic Information on Abstract Submission
1 Abstracts can only be submitted online through this Joint Meeting website (https://eschmischisb.confit.atlas.jp/login). Electronic submission works optimally with Microsoft Internet Explorer 10.0 or higher, Mozilla Firefox 5.0 or higher and Chrome 16 and Apple Safari 3 or higher.
2 Submitted abstracts should be prepared by following instruction below.
3 The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract handling, unless otherwise informed to the secretariat (eschm-isch-isb2021@congre.co.jp).
4 As ethical consideration, all animal and human studies must be approved by the corresponding institutional review boards and must comply with the guiding principles for experimental procedures or the Declaration of Helsinki of the World Medical Association.
5 Joint Meeting office and the secretariat do not correspond on the reasons of acceptance/rejection of an abstract.
6 Poster presentation is digital in the 2nd Joint Meeting of ESCHM-ISCH-ISB 2021. Please refer to the instruction of ePoster.
 
   
 
Please read the following instructions before submitting abstract.
1 The first author is responsible for ensuring that all co-authors have read and agreed the content of their abstract. The first author is responsible for the accuracy of the abstract, because changes of abstracts cannot be made after the deadline for abstract submission.
Please make sure all the information including co-authors' name and affiliation are registered correctly before the deadline.
2 Before you submit an abstract, we strongly recommend you to write your own abstract with other text files in advance and to copy and paste the text on the online abstract box of the website, instead of writing the abstract directly on the submission page. This will enable you to proofread all entries and make final changes before you submit them. Main text of an abstract should be less than 2,000 characters (about 230-250 words).
3 Your e-mail address is required for online abstract submission. Please make sure your e-mail address is valid so that we may contact you.
4 Abstracts can be re-edited and modified until submission deadline (May 10th, 2021). Therefore, the submitter will be required to keep the user account in the electronic online abstract submission system.
5 Confirmations and notifications of acceptance/rejection will be e-mailed to the registered address. If the e-mail address is not that of the presenting author, please make sure the first author receives the messages.
 
   
 
Notes for Abstract Submission
1 Online abstract submission has four parts, ‘Plenary Lecture’, ‘Keynote Lecture’, ‘Symposium’ and ‘Free Communication’. Please make sure that you select the correct part.
2 Some sessions in Symposium may accept abstract for Free Communication depending on the content and quality of the abstract. Please confirm the final program of the Joint Meeting for all the authors of abstracts.
3 In the case of Abstract for Free Communication, submitters are required to indicate their preference for oral or poster presentation. However, the decision of the presentation style is made by the scientific program committee.
4 The scientific program committee has all rights to publish the accepted abstract in the proceeding.
5 Any technical questions regarding the submission process should be directed to  eschm-isch-isb2021@congre.co.jp.
 
   
 
Instructions for Authors
Please read the following instructions carefully before submitting an abstract.
1 The corresponding author should be the first author of the abstract, unless otherwise noted during submission. The name, institution, and email address of the corresponding author must be provided as a contact information. The corresponding author will receive all future correspondence from the Joint Meeting office.
2 The acceptable length of the abstract is of 2,000 characters for standardization. This includes the authors’ details, titles and non-visible characters such as spaces and line breaks.
3 The presentation at the Joint Meeting must reflect the submitted abstract. In particular, the abstract title, authorship, and the content must match the submitted abstract appeared on proceeding, although updates on results may be added.
4 Full names of all authors should be fully indicated correctly and in the right order. The affiliations of all authors should be indicated fully with the laboratory, department and university/institution names without any abbreviations. Countries and cities of the affiliations also should be indicated.
5 The accepted abstracts will be published in the proceeding with the indicated authors’ and affiliations’ names without any corrections.
6 Structured abstract consisting of four sections (i.e., Background or Objectives, Methods, Results, and Conclusions) is recommended.
7 Images, tables, diagrams and graphs are not allowed to be included in the abstract.
8 Accepted abstracts will appear exactly as submitted at the Joint Meeting program. No revisions can be made after the abstract submission deadline.
9 Please keep your submission number and password until the deadline of submission. These are necessary to edit your abstract or communicate with meeting office. For security purposes, we are unable to answer any questions about passwords.
10 Abstracts generally may not be withdrawn once accepted. If the authors decide to withdraw the abstract for any reason, a written request for withdrawal must be submitted to eschm-isch-isb2021@congre.co.jp.
 
   
 
Disclosure of COI
Relevant Disclosure of Conflict of Interest (COI) is desirable in all the abstract submission for both Symposium and Free Communication in order to be free from commercial influence or bias.
1 For oral presentation, please use a slide to disclose COI at the beginning of the presentation. For poster presentation, please prepare and print out a slide to disclose COI, and put it at lower right of the poster panel.
2 In order to complete the COI disclosure declaration, please refer to the NIH public access PDF (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700754/pdf/nihms44451.pdf) or the following Table of Enforcement Regulation of COI as an example which is mostly accepted in Japanese academia.
 

1) If your study for this presentation is supported by research funds

2) If you are or have been an employee of a company and/or a profit-making organization related to medicine

3) If you have earned >¥1,000,000/year as an officer or advisor of a company and/or a profit-making organization related to medicine

4) If you hold>5% of the stock of a company and/or a profit-making organization related to medicine, or receive dividends >¥1,000,000/year

5) If you have earned >¥1,000,000/year as a patent fee from a company and/or a profit-making organization related to medicine

6) If you have earned >¥500,000/year as a lecture fee from a company and/or a profit-making organization related to medicine

7) If you have earned >¥500,000/year as a manuscript fee from a company and/or a profit-making organization related to medicine

8) If you have research expenses >¥1,000,000/year from a company and/or a profit-making organization related to medicine

9) If you have received >¥1,000,000/year as a certain contribution from a company and/or a profit-making organization related to medicine

10) If you are or have been involved in a certain endowed chair funded by a company and/or a profit-making organization related to medicine

11) If you have >¥1,000,000/year as a fee for expert comment, judgment or testimony in legal proceedings, or others from a company and/or a profit-making organization related to medicine

12) If you have received remuneration (travel, gifts, or other in-kind payments not directly related to research)equivalent to >¥50,000/year from a company and/or a profit-making organization related to medicine

13) If you are a representative of an organization for clinical study which receives research expenses (donation, contract, others)from a company and/or a profit-making organization related to medicine

  ¥1,000,000 corresponds approximately to 9,200 USD.
 
   
 
Selection of Abstract Review Category
Please refer to the list of abstract review categories to assist you in selecting the correct abstract classification, which leads to the greater possibility of abstract acceptance.
Be sure to select from the review category that best describes your abstract. Note that the abstract will be reviewed in the category you selected.
I. Abstract submission categories for both Symposium and Free Communication
1 Cellular Rheology and Bioiphysics
2 Clinical Hemorheology
3 Endothelial Function and Shear Stress
4 Red Blood Cell Deformability
5 Red Blood Cell Aggregation
6 Flow Visualization and Modeling
7 Disease and Hemorheology
8 Biorheology and Biotechnology
9 Miscellaneous (COVID-19, Food, Soft Matter, Interdisciplinary Sciences, and so on)
This abstract category is still tentative but the same as the free communication abstract submission categories of The 1st Joint Meeting.
 
   
 
Abstract Review and Selection Process
1 After the submission deadline, all completed and eligible abstracts will be made available to the Abstract Reviewers for blind peer review, and final decisions will be made by the scientific program committee.
2 Notification regarding acceptance or rejection of abstracts will be sent to the presenting author by email. If your abstract is accepted for Free Communication, the email will specify whether it is accepted as oral or poster presentation. If you have not received notification, contact eschm-isch-isb2021@congre.co.jp.
3 Some abstracts submitted for Free Communication may be selected for Symposia.
 
   
 
Abstract Awards
The 2nd Joint Meeting of ESCHM-ISCH-ISB prepares many types of abstract achievement awards for excellent abstracts, such as Rising Star Awards, Best Poster Presentation Award, and more! The details of these awards are under discussion with three parental Societies.
 
   
 
Publication in the Abstracts Issue of the Journal of Biorheology
1 All abstracts accepted for presentation at the 2nd Joint Meeting of ESCHM-ISCH-ISB 2021 will be published in the Abstract Issue of the Journal of Biorheology after this Joint Meeting.
2 The scientific program committee of the 2nd Joint Meeting of ESCHM-ISCH-ISB 2021 reserves the right not to publish abstracts that inappropriately promote commercial interests, abstracts that are judged unethical, poorly written, or scientifically unsound, or abstracts considered inappropriate for publication for other reasons as determined by the Program Committee.
3 Presenters can cancel publication of their own abstract in the Journal of Biorheology after the presentation at this Joint Meeting to avoid duplicate publication.
4 If you would like to cancel publication, contact eschm-isch-isb2021@congre.co.jp.
 
   
  page top